Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply. Alimentary pharmacology & therapeutics Kim, W. R., Telep, L. E., Chokkalingam, A. P. 2022; 55 (10): 1344-1345

View details for DOI 10.1111/apt.16920

View details for PubMedID 35472178